Zimmer Biomet (ZBH) PT Lowered to $175 at Jefferies

Zimmer Biomet (ZBH) PT Lowered to $175 at Citi

Citi analyst Joanna Wuensch lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.... More

Zimmer Biomet (ZBH) PT Lowered to $161 at BTIG

BTIG analyst Ryan Zimmerman lowered the price target on Zimmer Biomet (NYSE: ZBH) to $161.00 (from $173.00) while maintaining a Buy rating.... More

Zimmer Biomet (ZBH) PT Lowered to $140 at Deutsche Bank

Deutsche Bank analyst Pito Chickering lowered the price target on Zimmer Biomet (NYSE: ZBH) to $140.00 (from $160.00) while maintaining a Hold rating.... More

Zimmer Biomet (ZBH) PT Lowered to $180 at Guggenheim

Guggenheim analyst Chris Pasquale lowered the price target on Zimmer Biomet (NYSE: ZBH) to $180.00 (from $185.00) while maintaining a Buy rating.... More

Zimmer Biomet (ZBH) PT Lowered to $185 at Piper Sandler

Piper Sandler analyst Matthew O'Brien lowered the price target on Zimmer Biomet (NYSE: ZBH) to $185.00 (from $195.00) while maintaining a Overweight rating.... More

Zimmer Biomet (ZBH) PT Lowered to $165 at Morgan Stanley

Morgan Stanley analyst Drew Ranieri lowered the price target on Zimmer Biomet (NYSE: ZBH) to $165.00 (from $175.00) while maintaining a Overweight rating.... More

Zimmer Biomet (ZBH) PT Lowered to $175 at JMP Securities

JMP Securities analyst David Turkaly lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $195.00) while maintaining a Market Outperform rating.... More

Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities

Truist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.

The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More

Zimmer Biomet (ZBH) PT Raised to $175 at Cowen, Following Earnings

Cowen analyst Joshua Jennings raised the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $160.00) while maintaining a Market Perform rating.

Analyst says: "Based on the observations of late-3Q and the early weeks of 4Q, management has decided to lower its... More

Zimmer Biomet (ZBH) PT Lowered to $170 at Evercore ISI

Evercore ISI analyst Vijay Kumar lowered the price target on Zimmer Biomet (NYSE: ZBH) to $170.00 (from $180.00) while maintaining a Outperform rating.... More

Zimmer Biomet (ZBH) PT Lowered to $175 at Needham & Company

Needham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $187.00) while maintaining a Strong Buy rating.

The analyst commented, "ZBH's 3Q21 revenue missed while EPS beat consensus. Growth slowed due to procedure disruption and a tougher comp... More

Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 1c, Lowers FY Guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.81, $0.01 better than the analyst estimate of $1.80. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.96 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2021 EPS of $7.32-$7.47, versus the consensus of... More